Exiqon A/S to Divest CLIA Lab; Seeks Partners

Bookmark and Share

NEW YORK (GenomeWeb News) – Exiqon today said that it will divest its California-based CLIA lab, Oncotech, in an effort to “gain operational and infrastructural efficiencies and to free up human financial resources.”

MORE ON THIS TOPIC